litlas
ログインアカウント作成

Tito Fojo

1995–2025 年に発表

113
論文数
29,504
被引用数
83
h 指数
110
i10 指数

被引用数

Tito Fojo の年別被引用数1993 年: 被引用 1 件1995 年: 被引用 1 件1996 年: 被引用 3 件1997 年: 被引用 20 件1998 年: 被引用 56 件1999 年: 被引用 97 件2000 年: 被引用 164 件2001 年: 被引用 210 件2002 年: 被引用 204 件2003 年: 被引用 280 件2004 年: 被引用 285 件2005 年: 被引用 349 件2006 年: 被引用 317 件2007 年: 被引用 312 件2008 年: 被引用 289 件2009 年: 被引用 322 件2010 年: 被引用 299 件2011 年: 被引用 317 件2012 年: 被引用 312 件2013 年: 被引用 313 件2014 年: 被引用 336 件2015 年: 被引用 293 件2016 年: 被引用 255 件2017 年: 被引用 309 件2018 年: 被引用 246 件2019 年: 被引用 750 件2020 年: 被引用 730 件2021 年: 被引用 677 件2022 年: 被引用 433 件2023 年: 被引用 326 件2024 年: 被引用 479 件2025 年: 被引用 212 件2026 年: 被引用 5 件1994 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,340 件、この内訳の 28.9%中国: 引用元論文 1,269 件、この内訳の 11%ドイツ: 引用元論文 593 件、この内訳の 5.1%イギリス: 引用元論文 551 件、この内訳の 4.8%イタリア: 引用元論文 534 件、この内訳の 4.6%フランス: 引用元論文 437 件、この内訳の 3.8%日本: 引用元論文 377 件、この内訳の 3.3%カナダ: 引用元論文 334 件、この内訳の 2.9%オランダ: 引用元論文 318 件、この内訳の 2.7%インド: 引用元論文 295 件、この内訳の 2.5%オーストラリア: 引用元論文 263 件、この内訳の 2.3%スペイン: 引用元論文 233 件、この内訳の 2%
0%28.9%その他 26.1%

機関

分野

  • Medicine52%
  • Biochemistry, Genetics and Molecular Biology33.2%
  • Materials Science3.3%
  • Engineering2%
  • Computer Science2%
  • Immunology and Microbiology1.8%
  • その他5.7%

トピック

  • Drug Transport and Resistance Mechanisms5.9%
  • Cancer Cells and Metastasis3.6%
  • Cancer, Hypoxia, and Metabolism3%
  • Adrenal and Paraganglionic Tumors2.3%
  • Cancer-related Molecular Pathways2.1%
  • Microtubule and mitosis dynamics2.1%
  • その他81%

共著者

全論文

検索で開く
  1. Multidrug resistance in cancer: role of ATP–dependent transporters

    著者: Michael M. Gottesman, Tito Fojo, Susan E. Bates - Nature reviews. Cancer 2002 被引用: 5,519

  2. Tumour stem cells and drug resistance

    著者: Michael Dean, Tito Fojo, Susan E. Bates - Nature reviews. Cancer 2005 被引用: 3,658

  3. Combination Chemotherapy in Advanced Adrenocortical Carcinoma

    著者: Martin Faßnacht, Massimo Terzolo, Bruno Allolio, Éric Baudin, Harm R. Haak, Alfredo Berruti, Staffan Welin, Carmen Schade‐Brittinger, André Lacroix, Barbara Jarząb, Halfdan Sørbye, David J. Torpy, Vinzenz Stepan, D.E. Schteingart, Wiebke Arlt, Matthias Kroiß, Sophie Leboulleux, Paola Sperone, Anders Sundin, I G C Hermsen, Stefanie Hahner, Holger S. Willenberg, Antoine Tabarin, Marcus Quinkler, Christelle de la Fouchardière, Martin Schlumberger, Franco Mantero, Dirk Weismann, Felix Beuschlein, Hans Gelderblom, Hanneke Wilmink, Monica Sender, Maureen Edgerly, W. Kenn, Tito Fojo, Hans‐Helge Müller, Britt Skogseid - New England Journal of Medicine 2012 被引用: 864

  4. Early Readout on Overall Survival of Patients With Melanoma Treated With Immunotherapy Using a Novel Imaging Analysis

    著者: Laurent Dercle, Binsheng Zhao, Mithat Gönen, Chaya S. Moskowitz, Firas Ahmed, Volkan Beylergil, Dana E. Connors, Hao Yang, Lin Lü, Tito Fojo, Richard D. Carvajal, Sanja Karovic, Michael L. Maitland, Gregory Goldmacher, Geoffrey R. Oxnard, Michael A. Postow, Lawrence H. Schwartz - JAMA Oncology 2022 被引用: 92

  5. Delivering affordable cancer care in high-income countries

    著者: Richard Sullivan, Jeffrey Peppercorn, Karol Sikora, John Zalcberg, Neal J. Meropol, Eitan Amir, David Khayat, Peter Boyle, Philippe Autier, Ian F. Tannock, Tito Fojo, Jim Siderov, Steve Williamson, Silvia Camporesi, J. Gordon McVie, Arnie Purushotham, Peter Naredi, Alexander Eggermont, Murray F. Brennan, Michael L. Steinberg, Mark De Ridder, Susan A. McCloskey, Dirk Verellen, Terence Roberts, Guy Storme, Rodney J. Hicks, Peter J. Ell, Bradford R. Hirsch, David P. Carbone, Kevin A. Schulman, Paul Catchpole, David Taylor, Jan Geißler, Nancy Brinker, David Meltzer, David Kerr, Matti Aapro - The Lancet Oncology 2011 被引用: 714

  6. The Role of ABC Transporters in Clinical Practice

    著者: Gregory D. Leonard, Tito Fojo, Susan E. Bates - The Oncologist 2003 被引用: 823

  7. SomaticHIF2AGain-of-Function Mutations in Paraganglioma with Polycythemia

    著者: Zhengping Zhuang, Chunzhang Yang, Felipe Lorenzo, Maria J. Merino, Tito Fojo, Electron Kebebew, Vera Popović, Constantine A. Stratakis, Josef T. Prchal, Karel Pacák - New England Journal of Medicine 2012 被引用: 392

  8. Mitosis is not a key target of microtubule agents in patient tumors

    著者: Edina Komlódi-Pásztor, Dan L. Sackett, Julia Wilkerson, Tito Fojo - Nature Reviews Clinical Oncology 2011 被引用: 306

  9. Management of phaeochromocytoma and paraganglioma in patients with germline SDHB pathogenic variants: an international expert Consensus statement

    著者: David Taïeb, Svenja Nölting, Nancy D. Perrier, Martin Faßnacht, Jorge A. Carrasquillo, Ashley Grossman, Roderick Clifton‐Bligh, George B. Wanna, Zachary G. Schwam, Laurence Amar, Isabelle Bourdeau, Ruth Casey, Joakim Crona, Cheri Deal, Jaydira Del Rivero, Quan‐Yang Duh, Graeme Eisenhofer, Tito Fojo, Hans K. Ghayee, Anne‐Paule Gimenez‐Roqueplo, Anthony J. Gill, Rodney J. Hicks, Alessio Impériale, Abhishek Jha, Michiel N. Kerstens, Ronald R. de Krijger, André Lacroix, Ivica Lazúrová, Frank I. Lin, Charlotte Lussey‐Lepoutre, Eamonn R. Maher, Özgür Mete, Mitsuhide Naruse, Naris Nilubol, Mercedes Robledo, F. Sébag, Nalini S. Shah, Akiyo Tanabe, Geoffrey B. Thompson, Henri Timmers, J Widimský, William J. Young, Leah Meuter, Jacques W.M. Lenders, Karel Pacák - Nature Reviews Endocrinology 2023 被引用: 90

  10. Current Approaches and Recent Developments in the Management of Head and Neck Paragangliomas

    著者: David Taïeb, Alexandre Kaliski, Carsten C. Boedeker, Victoria Martucci, Tito Fojo, John R. Adler, Karel Pacák - Endocrine Reviews 2014 被引用: 168

  11. Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes.

    著者: Keisuke Miyake, Lyn A. Mickley, Thomas Litman, Zhirong Zhan, Robert W. Robey, B Cristensen, Mariafiorella Brangi, L Greenberger, Michael Dean, Tito Fojo, Susan E. Bates - 1999 被引用: 822

  12. Characteristics And Outcomes Of Metastatic Sdhb And Sporadic Pheochromocytoma/Paraganglioma: An National Institutes Of Health Study

    著者: Hana Turková, Tamara Prodanov, Marek Malý, Victoria Martucci, Karen T. Adams, J Widimský, Clara C. Chen, Alexander Ling, Electron Kebebew, Constantine A. Stratakis, Tito Fojo, Karel Pacák - Endocrine Practice 2015 被引用: 134

  13. Precision oncology: origins, optimism, and potential

    著者: Vinay Prasad, Tito Fojo, Michael Brada - The Lancet Oncology 2016 被引用: 256

  14. Metastatic Pheochromocytoma/Paraganglioma Related to Primary Tumor Development in Childhood or Adolescence: Significant Link to SDHB Mutations

    著者: Kathryn S. King, Tamara Prodanov, Vitaly Kantorovich, Tito Fojo, Jacqueline Hewitt, Margaret Zacharin, Robert Wesley, Maya Lodish, Margarita Raygada, Anne‐Paule Gimenez‐Roqueplo, Shana E. McCormack, Graeme Eisenhofer, Dragana Milosevic, Electron Kebebew, Constantine A. Stratakis, Karel Pacák - Journal of Clinical Oncology 2011 被引用: 198

  15. A Pharmacodynamic Study of Docetaxel in Combination with the P-glycoprotein Antagonist Tariquidar (XR9576) in Patients with Lung, Ovarian, and Cervical Cancer

    著者: Ronan J. Kelly, Deborah Draper, Clara C. Chen, Robert W. Robey, William D. Figg, Richard Piekarz, Xiaohong Chen, Erin R. Gardner, Frank M. Balis, Aradhana M. Venkatesan, Seth M. Steinberg, Tito Fojo, Susan E. Bates - Clinical Cancer Research 2010 被引用: 172

  16. The evidence framework for precision cancer medicine

    著者: Jeffrey A. Moscow, Tito Fojo, Richard L. Schilsky - Nature Reviews Clinical Oncology 2017 被引用: 168

  17. Emerging Therapeutic Implications of STK11 Mutation: Case Series

    著者: Bahar Laderian, Prabhjot S. Mundi, Tito Fojo, Susan E. Bates - The Oncologist 2020 被引用: 56

  18. Treatment of malignant pheochromocytoma/paraganglioma with cyclophosphamide, vincristine, and dacarbazine

    著者: Hui Huang, Jame Abraham, Elizabeth Hung, Steven D. Averbuch, Maria J. Merino, Seth M. Steinberg, Karel Pacák, Tito Fojo - Cancer 2008 被引用: 252

  19. Oxaliplatin, tetraplatin, cisplatin, and carboplatin: Spectrum of activity in drug-resistant cell lines and in the cell lines of the national cancer institute's anticancer drug screen panel

    著者: Olivier Rixe, Waldo Ortuzar, Manuel Álvarez, R. R. Parker, Eddie Reed, K Paull, Tito Fojo - Biochemical Pharmacology 1996 被引用: 615

  20. Unintended Consequences of Expensive Cancer Therapeutics—The Pursuit of Marginal Indications and a Me-Too Mentality That Stifles Innovation and Creativity

    著者: Tito Fojo, Sham Mailankody, Andrew W. Lo - JAMA Otolaryngology–Head & Neck Surgery 2014 被引用: 301

  21. Multiple paths to a drug resistance phenotype: Mutations, translocations, deletions and amplification of coding genes or promoter regions, epigenetic changes and microRNAs☆

    著者: Tito Fojo - Drug Resistance Updates 2007 被引用: 187

  22. Baseline Radiomic Signature to Estimate Overall Survival in Patients With NSCLC

    著者: Laurent Dercle, Matthew Fronheiser, Naiyer A. Rizvi, Matthew D. Hellmann, Sabine Maier, Wendy Hayes, Hao Yang, Pingzhen Guo, Tito Fojo, Lawrence H. Schwartz, Binsheng Zhao, David Leung - Journal of Thoracic Oncology 2023 被引用: 25

  23. Paclitaxel-resistant Human Ovarian Cancer Cells Have Mutant β-Tubulins That Exhibit Impaired Paclitaxel-driven Polymerization

    著者: Paraskevi Giannakakou, Dan L. Sackett, Yoon‐Koo Kang, Zhirong Zhan, Jeroen Buters, Tito Fojo, Marianne S. Poruchynsky - Journal of Biological Chemistry 1997 被引用: 682

  24. A common pharmacophore for epothilone and taxanes: Molecular basis for drug resistance conferred by tubulin mutations in human cancer cells

    著者: Paraskevi Giannakakou, Rick Gussio, Eva Nogales, Kenneth H. Downing, Daniel Zaharevitz, Birgit Bollbuck, George Poy, Dan L. Sackett, K. C. Nicolaou, Tito Fojo - National Academy of Sciences, Proceedings of the National Academy of Sciences 2000 被引用: 477